C12Y 204/01225
N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase
Official title: N-Acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase (2.4.1.225)
C12Y204/01225 (N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase) appears on 0 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 4
- Assignees
- 4
- Inventors
- 12
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
No granted patents in this class yet.
- Targeting creb-heparan sulfate-fgf pathway for cancer treatment1 Jan 2026US 2026/0000689 A1University of South Florida
- Heparin sulfate biosynthesis pathway enzyme irna agent compositions and methods of use thereof13 Mar 2025US 2025/0084417 A1Alnylam Pharmaceuticals, Inc.
- Cell lines with improved aav production capacity16 Jan 2025US 2025/0019669 A1The Children’s Hospital of Philadelphia
- Depletion of ext1 expression and/or activity improves cellular production of biological entities1 Jun 2023US 2023/0167449 A1Universite De Liege
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.